References
- Schwarzel W. C., Kruggel W., Brodie H. J. Studies on the mechanism of estrogen biosynthesis. VII. The development of inhibitors of the enzyme system in human placenta. Endocrinology 1973; 92: 866–880
- Brodie A. M.H., Schwarzel W. C., Shaikh A. A., Brodie H. J. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology 1977; 100: 1684–1695
- Santen R. J., Santner S., Davis B., Veldhuis J., Samojlik E., Ruby E. Aminog-lutethimide inhibits extraglandular oestrogen production in postmenopausal women with breast carcinoma. J. Clin. Endocrinol. Metab. 1978; 47: 1257–1265
- Coombes R. C., Goss P., Dowsett M., Gazet J. C., Brodie A. M.H. 4-Hydroxyandros-tenedione treatment of postmenopausal patients with advanced breast cancer. The Lancet 1984; 2: 1237–1239
- Goss P. E., Coombes R. C., Powles T. J., Dowsett M., Brodie A. M.H. Treatment of advanced postmenopausal breast cancer with aromatase inhibitor, 4-hydroxyandrostenedione Phase 2 report. Cancer Res. 1986; 46: 4823–4826
- Coombes R. C., Stein R. C., Dowsett M. Aromatase inhibitors in human breast cancer. Proc. R. Soc. Edinb. 1989; 95B: 283–292
- Hofien K., Jonat W., Possinger K., Kolbel M., Kunz T., Wagner H., Becher R., Callies R., Friederich P., Willmanns W., Maass H., Schmidt C. G. J. Clin. Oncology 1990, in press
- Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. New Engl. J. Med. 1988; 319: 1681–1692
- Corbin C. J., Graham-Lorence S., McPhaul M., Mason J. I., Mendelson C. R., Simpson E. R. Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc. Natl. Acad. Sci. USA 1988; 85: 8948–8952
- Simpson E. R., Merrill J. C., Hollub A. J., Graham-Lorence S., Mendelson C. R. Regulation of estrogen biosynthesis by human adipose cells. Endocrine Rev. 1989; 10: 136–148
- Manni A., Pearson O. H. Antiestrogen induced remissions in premenopausal women with stage IV breast cancer: affects on ovarian function. Cancer Treatment Rep. 1980; 64: 111–116
- Brodie A. M.H., Hammond J. O., Ghosh M., Meyer K., Albrecht E. The effect of treatment with aromatase inhibitor 4-OHA on the primate menstrual cycle. Cancer Rex 1989; 49: 4780–4784